Regulation of Focal Adhesion Kinase Signaling by Death‐Associated Protein Kinase 3 in Vascular Smooth Muscle Cells
Journal of Cellular Biochemistry · 2026-11 · 127 (11)
DOI: 10.1002/jcb.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, online erschienen am 15.11.2026. Verfasst von Abdulhameed Al-Ghabkari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada. Hauptthemen laut MEDLINE: Death-Associated Protein Kinases, Muscle, Smooth, Vascular, Signal Transduction, Myocytes, Smooth Muscle. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Death‐associated protein kinase 3 (DAPK3) is a Ser/Thr protein kinase with regulatory involvement in the motility and contractility of vascular smooth muscle cells (VSMC). DAPK3 silencing can induce cytoskeletal remodeling with disassembly of actin stress fiber networks and coincident loss of focal adhesion kinase (FAK)‐pY397 phosphorylation. The link between DAPK3 inhibition and FAK phosphorylation is unknown, and critical interactor(s) and regulator(s) are not yet defined. In this study, we further analyzed the DAPK3‐FAK relationship in VSMCs. As expected, the application of HS38, a selective DAPK inhibitor, to coronary artery vascular smooth muscle cells (CASMCs) suppressed myosin light chain diphosphorylation (LC20, pT18&pS19) and the inhibitory phosphorylation of myosin phosphatase regulators, MYPT1 (pT696) and CPI‐17 (pT38). The suppression of DAPK3 signaling was also associated with a significant decline in FAK‐pY397 phosphorylation (but not pY576). These molecular events were associated with the translocation of cytoplasmic FAK to the nucleus and a loss of CASMC cell migration potential. DAPK3 inhibition with HS38 or silencing with a DAPK3‐siRNA could also attenuate the phosphorylation of other focal adhesion components (p130Cas and paxillin) and the activation of downstream pathways (ERK). Collectively, the data presented herein strongly support a regulatory mechanism for DAPK3 in the indirect control of FAK and focal adhesion signaling in VSMCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
- Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA.
ORCID-Profile: David A Carlson, Timothy A J Haystead, Justin A MacDonald
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Al-Ghabkari, A., Carlson, D. A., Haystead, T. A. J., & MacDonald, J. A. (2026). Regulation of Focal Adhesion Kinase Signaling by Death‐Associated Protein Kinase 3 in Vascular Smooth Muscle Cells. Journal of Cellular Biochemistry, 127(11). https://doi.org/10.1002/jcb.70139
Vancouver
Al-Ghabkari A, Carlson DA, Haystead TAJ, MacDonald JA. Regulation of Focal Adhesion Kinase Signaling by Death‐Associated Protein Kinase 3 in Vascular Smooth Muscle Cells. Journal of Cellular Biochemistry. 2026;127(11). doi:10.1002/jcb.70139
BibTeX
@article{AlGhabkari2026,
author = {Al-Ghabkari, Abdulhameed and Carlson, David A and Haystead, Timothy A J and MacDonald, Justin A},
title = {Regulation of Focal Adhesion Kinase Signaling by Death‐Associated Protein Kinase 3 in Vascular Smooth Muscle Cells},
journal = {Journal of Cellular Biochemistry},
year = {2026},
volume = {127},
number = {11},
doi = {10.1002/jcb.70139}
}
EUVIMED